Fundraising Fox

Agile Therapeutics

Princeton, US · Delaware corporation · 8 employees on LinkedIn · 2 known investors

Agile Therapeutics develops and markets contraceptive and women's health products using its proprietary Skinfusion® transdermal technology platform. The company focuses on providing healthcare options for women through innovative delivery mechanisms.

Founders & leadership

KM
Katie MacFarlaneinExecutive
SM
Scott M. CoianteExecutive
AA
Al AltomariinExecutive
EG
Elizabeth GarnerinExecutive

Board

KH
Karen HongBoard director
AL
Abhijeet LeleBoard director
ANAndrew N. Schiff
Andrew N. SchiffinBoard directorManaging Partner at Aisling Capital
LP
Lorenzo PellegriniBoard director
WT
William T. McKeeBoard director
JH
John HubbardBoard director
JT
James TursiBoard director

Investors · 2

Reported raises · per SEC filings

Form D private placements

$30.8M disclosed across 3 rounds · 2014–2019

$7.8MraisedMar 2019 · 1 investors · Pharmaceuticals
Rule 506(b)
Officers, directors & promoters on the filing
  • Seth H.Z. FischerDirector
  • William T. McKeeDirector
  • James P. TursiDirector
  • Abhijeet LeleDirector
  • Scott M. CoianteExecutive Officer
  • Al AltomariExecutive Officer, Director
  • Elizabeth GarnerExecutive Officer
  • Ajit S. ShettyDirector
  • John HubbardDirector
  • Robert G. ConwayExecutive Officer
  • Geoffrey P. GilmoreExecutive Officer
Offering amount
$7.8M
Amount sold
$7.8M
First sale
Mar 2019
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
$20MraisedFeb 2015 · 8 investors · Pharmaceuticals
Rule 506(b)
Officers, directors & promoters on the filing
  • Katie MacFarlaneExecutive Officer
  • Karen HongDirector
  • William T. McKeeDirector
  • John HubbardDirector
  • Scott M. CoianteExecutive Officer
  • Al AltomariExecutive Officer, Director
  • Abhijeet LeleDirector
  • Elizabeth GarnerExecutive Officer
  • Andrew N. SchiffDirector
  • James TursiDirector
Offering amount
$20M
Amount sold
$20M
Sales commissions
$600K
Placement agents
William Blair & Company, L.L.C.
First sale
Jan 2015
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
$3MraisedMay 2014 · 9 investors · Pharmaceuticals
Rule 506(b)
Officers, directors & promoters on the filing
  • Katie MacFarlaneExecutive Officer
  • Elizabeth GarnerExecutive Officer
  • Karen HongDirector
  • Al AltomariExecutive Officer, Director
  • Scott M. CoianteExecutive Officer
  • Andrew N. SchiffDirector
  • Abhijeet LeleDirector
  • William T. McKeeDirector
  • Lorenzo PellegriniDirector
Offering amount
$3M
Amount sold
$3M
Proceeds to insiders
$300K
First sale
Apr 2014
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Competitors · 4

by search overlap

Companies competing with Agile Therapeutics for the same Google search keywords, organic and paid, via search-intersection analysis.

Frequently asked questions

What does Agile Therapeutics do?
Agile Therapeutics develops and markets contraceptive and women's health products using its proprietary Skinfusion® transdermal technology platform. The company focuses on providing healthcare options for women through innovative delivery mechanisms.
Who are Agile Therapeutics's investors?
Agile Therapeutics's investors include Aisling Capital, Kaiser Permanente Ventures.
How much funding has Agile Therapeutics raised?
Agile Therapeutics has disclosed $30.8M raised across 3 rounds.
Where is Agile Therapeutics headquartered?
Agile Therapeutics is headquartered in Princeton, US.